Literature DB >> 14984368

Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.

Hsueh-Hsiao Wang1, An-Na Chiang.   

Abstract

Beta2-glycoprotein I (beta2-GPI) is a plasma glycoprotein primarily synthesized in the liver. The interindividual variability of beta2-GPI expression in subjects with various metabolic syndromes and disease states suggests that it may have clinical importance. However, the regulation of beta2-GPI gene expression has not been clarified. To gain more insight into the control of beta2-GPI gene expression, we cloned the 4.1-kb 5'-flanking region and characterized the proximal promoter of the beta2- GPI gene in this study. Cis -acting elements required for beta2-GPI promoter activity were identified with transient transfection assays in the hepatoma cell lines HepG2 and Huh7 and in non-hepatic HeLa cells. Serial deletion analyses of the beta2-GPI 5'-flanking sequence revealed that the region from -197 to +7 had strong promoter activity in hepatoma cells but not in HeLa cells. Truncation and site-directed mutagenesis of putative cis -elements within this region showing an atypical TATA box and a HNF-1 (hepatic nuclear factor-1) element were both essential for the beta2-GPI promoter activity. Subsequent gel mobility shift assays confirmed the interaction of HNF-1alpha with the HNF-1 site residing downstream of the TATA box. Co-transfection of beta2-GPI promoter-luciferase vector with HNF-1alpha expression vector in Huh7 and HNF-1-deficient HeLa cells demonstrated the transactivation effect of HNF-1alpha on beta2-GPI promoter activity. In addition, overexpression of HNF-1alpha enhanced the endogenous beta2-GPI expression. These results suggest that the atypical TATA box and HNF-1 cis-element are critical for beta2-GPI transcription and HNF-1alpha may play an important role in cell-specific regulation of beta2-GPI gene expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984368      PMCID: PMC1224180          DOI: 10.1042/BJ20031610

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Assignment of apolipoprotein H (APOH: beta-2-glycoprotein I) to human chromosome 17q23----qter; determination of the major expression site.

Authors:  A Steinkasserer; D J Cockburn; D M Black; Y Boyd; E Solomon; R B Sim
Journal:  Cytogenet Cell Genet       Date:  1992

2.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

3.  Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene.

Authors:  L K McGlynn; C R Mueller; M Begbie; C R Notley; D Lillicrap
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

4.  Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.

Authors:  A R Cabral; J Cabiedes; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1995-10       Impact factor: 4.666

5.  Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations.

Authors:  H Mehdi; C E Aston; D K Sanghera; R F Hamman; M I Kamboh
Journal:  Hum Genet       Date:  1999 Jul-Aug       Impact factor: 4.132

6.  Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.

Authors:  R A Roubey; C W Pratt; J P Buyon; J B Winfield
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (beta 2-glycoprotein I).

Authors:  J R Day; P J O'Hara; F J Grant; C Lofton-Day; M N Berkaw; P Werner; P Arnaud
Journal:  Int J Clin Lab Res       Date:  1992

8.  Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA.

Authors:  T Kristensen; I Schousboe; E Boel; E M Mulvihill; R R Hansen; K B Møller; N P Møller; L Sottrup-Jensen
Journal:  FEBS Lett       Date:  1991-09-09       Impact factor: 4.124

9.  Members of the CAAT/enhancer-binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha-fetoprotein promoter and enhancer.

Authors:  B Bois-Joyeux; J L Danan
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

Review 10.  HNF1, a homeoprotein member of the hepatic transcription regulatory network.

Authors:  F Tronche; M Yaniv
Journal:  Bioessays       Date:  1992-09       Impact factor: 4.345

View more
  2 in total

1.  Functional and genetic characterization of the promoter region of apolipoprotein H (beta2-glycoprotein I).

Authors:  Sangita Suresh; F Yesim Demirci; Iliya Lefterov; Candace M Kammerer; Rosalind Ramsey-Goldman; Susan Manzi; M Ilyas Kamboh
Journal:  FEBS J       Date:  2010-01-18       Impact factor: 5.542

2.  Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2-glycoprotein-I) gene and serum lipid levels.

Authors:  Tao Guo; Rui-Xing Yin; Hui Li; Yi-Ming Wang; Jin-Zhen Wu; De-Zhai Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.